Literature DB >> 9284085

Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production.

R Muniyappa1, M F Walsh, J S Rangi, R M Zayas, P R Standley, J L Ram, J R Sowers.   

Abstract

Insulin like growth factor 1 (IGF-1) vasodilates, increases blood flow and lowers blood pressure; nitric oxide (NO) has been suggested to mediate some of these effects. We studied the role of IGF-1 in the regulation of NO production in vascular smooth muscle cells (VSMC). IGF-1 induced a concentration and time-dependent increase in NO release from endothelium-denuded aortic rings. Pre-incubation with cycloheximide or aminoguanidine blocked IGF-1-stimulated NO release. In addition, a six-fold increase in NO production by VSMC was seen upon incubation with IGF-1. These results suggest that IGF-1 induces NO release in VSMC through a process that involves new protein synthesis and the inducible isoform of nitric oxide synthase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284085     DOI: 10.1016/s0024-3205(97)00594-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells.

Authors:  Esma R Isenovic; Yong Meng; Andras Divald; Nikola Milivojevic; James R Sowers
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly.

Authors:  Federico Gatto; Claudia Campana; Francesco Cocchiara; Giuliana Corica; Manuela Albertelli; Mara Boschetti; Gianluigi Zona; Diego Criminelli; Massimo Giusti; Diego Ferone
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

3.  Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR.

Authors:  Madankumar Ghatge; Jiny Nair; Ankit Sharma; Rajani Kanth Vangala
Journal:  Mol Med Rep       Date:  2018-01-08       Impact factor: 2.952

4.  Cardiovascular action of insulin-like growth factor-1 is not mediated by calcitonin gene-related peptide neurons.

Authors:  Crystal R McRae; Sumangala P Rao; Joseph C Dunbar
Journal:  Endocrine       Date:  2002-11       Impact factor: 3.633

5.  The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese.

Authors:  Eva Pardina; Roser Ferrer; Juan Antonio Baena-Fustegueras; Albert Lecube; Jose Manuel Fort; Víctor Vargas; Roberto Catalán; Julia Peinado-Onsurbe
Journal:  Obes Surg       Date:  2010-05       Impact factor: 4.129

6.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

7.  Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study.

Authors:  John H Page; Jing Ma; Michael Pollak; Joann E Manson; Susan E Hankinson
Journal:  Clin Chem       Date:  2008-08-14       Impact factor: 8.327

8.  IGF-1 Increases with Hyperbaric Oxygen Therapy and Promotes Wound Healing in Diabetic Foot Ulcers.

Authors:  Figen Aydin; Ahmet Kaya; Levent Karapinar; Mert Kumbaraci; Ahmet Imerci; Hasan Karapinar; Cengiz Karakuzu; Mustafa Incesu
Journal:  J Diabetes Res       Date:  2013-02-26       Impact factor: 4.011

Review 9.  GH and the cardiovascular system: an update on a topic at heart.

Authors:  Jörgen Isgaard; Michele Arcopinto; Kristjan Karason; Antonio Cittadini
Journal:  Endocrine       Date:  2014-06-28       Impact factor: 3.633

Review 10.  Growth Hormone (GH) and Cardiovascular System.

Authors:  Diego Caicedo; Oscar Díaz; Pablo Devesa; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2018-01-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.